BSECompany Update11 Aug 2026 · 11 Aug 2026, 07:56 pm

Investor Meet

Biocon Ltd · 532523

✦ AI SummaryOrder Win

Biocon Ltd has scheduled a meeting with analysts/institutional investors as part of the Motilal Oswal 22nd Annual Global Investor Conference on August 17, 2026, in Mumbai. The meeting is subject to change due to exigencies. The company will not disclose any unpublished price-sensitive information during the meeting.

Analysis Scores

Earnings Impact5/10
Growth Catalyst6/10
Governance Concern2/10
Regulatory Risk1/10
Balance Sheet Risk3/10
Liquidity Impact8/10
Market Sentiment7/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Biocon Ltd - 532523 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Attachments (1)

📄

e3b7487c-0a30-4bc8-a08a-eee529c650e9.pdf

pdf

Download →
View document text
Biocon Limited 20th KM, Hosur Road Electronic City Bangalore 560 100, India T 91 80 2808 2808 F 91 80 2852 3423 CIN : L24234KA1978PLC003417 www.biocon.com BIO/SECL/TG/2026-27/59 August 11, 2026 To, To, The Secretary The Secretary BSE Limited National Stock Exchange of India Limited Department of Corporate Services Corporate Communication Department Phiroze Jeejeebhoy Towers, Exchange Plaza, Bandra Kurla Complex Dalal Street, Mumbai – 400 001 Mumbai – 400 051 Scrip Code - 532523 Scrip Symbol - BIOCON Dear Sir/ Madam, Sub: Intimation of Schedule of Meetings with Analyst(s)/Institutional Investor(s) Pursuant to Regulation 30(6) of the SEBI Listing Regulations, we wish to inform you that the Management of the Company is scheduled to meet with the Analyst(s)/Institutional Investor(s) as per the details given below: Type of Date Event Venue Interaction 1x1/Group/In- 17-Aug-26 Motilal Oswal 22nd Annual Global Investor Conference Mumbai Person Note: The above-mentioned schedule is subject to change due to exigencies on the part of Investors/Company. Kindly note that the Company will not disclose any Unpublished Price Sensitive Information (UPSI) during the analyst(s)/ investor(s) meeting. The above information will also be available on the website of the Company at www.biocon.com. We request you to kindly take the above information on record. Thanking You, Yours faithfully, For Biocon Limited Rajesh U. Shanoy Company Secretary and Compliance Officer Membership No.: ACS 16328